ZAGREB, 18 Dec (Hina) - The Pliva pharmaceutical company will focus more on producing innovative medicines in the future and as of 2024 over 50% of research and development investments will be directed towards this goal, Pliva Management Board Chair Mihael Furjan said at an annual press conference on Monday.
Pliva to focus more on innovative medicine in future
Only logged-in users can see full content details